Actively Recruiting
Study of Fertility-Sparing Treatment in Women Aged 18 to 45 With Early Stage IA Endometrial Cancer
Led by Peking University People's Hospital · Updated on 2023-07-14
57
Participants Needed
1
Research Sites
208 weeks
Total Duration
AI-Summary
What This Trial Is About
This research focuses on patients with Stage IA endometrial adenocarcinoma who have either no myometrial invasion or less than half myometrial invasion. The goal is to explore the feasibility and outcomes of fertility-sparing therapy in these patients, comparing those with myometrial invasion to those without. The study aims to see if fertility-sparing treatment can be safely extended to patients with limited myometrial invasion. Participants will receive an indication-extended fertility-sparing therapy that begins with oral medroxyprogesterone acetate or megestrol acetate. If there is no response after 6 months, treatment can be changed to a levonorgestrel intrauterine system combined with monthly injections of gonadotropin-releasing hormone agonists. After complete remission, consolidation treatment continues for 1 to 3 months. Depending on pregnancy intentions, patients may receive maintenance treatment or be encouraged to conceive naturally or with assisted reproductive technology. The study groups include those with less than half myometrial invasion and those with no invasion. Participants will be followed every 3 to 6 months for up to five years. Researchers will monitor remission rates at various time points, recurrence rates, pregnancy rates, and pregnancy outcomes. Blood tests and pathological markers will be assessed regularly alongside monitoring for any adverse reactions. The primary outcome is the complete remission rate after 9 months of treatment. This long-term follow-up will help evaluate safety and effectiveness of fertility-sparing treatment in this patient group.
CONDITIONS
Brief Title
Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer
Research Team
J
Jianliu Wang, Professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here